Clinical trial
A 12-week, Parallel, Double-blind, Randomised, Placebo-controlled Adjunctive Study of Taurine 4 Grams in 128 Patients With First-episode Psychosis Receiving Antipsychotic Treatment.
NCT00420823 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 12-week, Parallel, Double-blind, Randomised, Placebo-controlled Adjunctive Study of Taurine 4 Grams in 128 Patients With First-episode Psychosis Receiving Antipsychotic Treatment.
- Lead sponsor
- Melbourne Health
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- December 31, 2010
- Enrollment
- 121 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.